Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Plc Regulatory News (HAYD)

Share Price Information for Haydale Plc (HAYD)

Share Price is delayed by 15 minutes
Get Live Data
0.325    -0.0025 (-0.76%)
Bid:
0.32
Ask:
0.33
Spread: 0.01 (3.125%)
Market Cap: £25.27m
HAYD Live PriceLast checked at - London Stock Exchange

Intraday Haydale Plc Share Chart

Marketing Agreement

4 Aug 2014 07:00

HAYDALE GRAPHENE INDUSTRIES PLC - Marketing Agreement

HAYDALE GRAPHENE INDUSTRIES PLC - Marketing Agreement

PR Newswire

London, August 3

Haydale Graphene Industries plc ("Haydale" or the "Company") Marketing Agreement with planarTECH LLC for Asia-Pacific region Haydale Graphene Industries plc (AIM:HAYD), the Company focused on enablingtechnology for the commercialisation of graphene, is pleased to announce it hasentered into a marketing agreement with planarTECH LLC. ("planarTECH")("Agreement"), to accelerate the commercialisation of graphene across theAsia-Pacific region ("APAC"). The Agreement is a rolling annual contract and will focus on the marketing anddistribution of Haydale HDPlas® functionalised graphene nanoplatelets, inks,few layered graphenes, multi-walled and single/double walled carbon nanotubes. With over 15 years of experience in the synthesis of CNTs and graphene,planarTECH has continually developed graphene process know-how and connectionsto leading research institutions in Korea, the US and Europe. They will marketand promote Haydale's functionalised nanomaterial products to potential R&Dcustomers and commercial partners specifically in China, Japan, Korea andTaiwan. A warrant agreement has been entered into between the Company and planarTECHwhich grants planarTECH up to 20,000 warrants to subscribe for ordinary sharesof £ 0.02p each in the Company ("Ordinary Shares") at an exercise price of £1.60 subject to the satisfaction of certain vesting conditions relating to therevenues generated by planarTECH for the Company in the period to 30 June 2015.These warrants have an exercise period beginning 1 July 2015 and ending 30 June2018. Following this agreement Haydale now has 1,041,215 options and warrantsoutstanding over Ordinary Shares representing 9.26% per cent. of the Company'stotal issued share capital. Ray Gibbs, CEO at Haydale, commented: "The ability to fully commercialise graphenes has been a stumbling block forthe industry, particularly in the APAC region where the majority of patents forgraphene-based applications originate. planarTECH's industry knowledge andconnections are substantial with a track record of success in the region. Thisagreement should enable Haydale to significantly increase its presence in amajor rapidly growing market. We expect this agreement to allow a greaternumber of potential R&D customers to test and analyse our plasma functionalisedmaterials for integration into their specific products and applications. We areexcited to be working with the hugely knowledgeable team at planarTECH - a teamwith in-depth experience of the graphene and 2D materials market landscape, aswell as market entry advice and access to top-tier OEM partners across Asia." Patrick Frantz, President and CEO of planarTECH, commented: "We're very pleased to be working with Haydale to bring its unique plasmafunctionalisation technology to customers in Asia, and we've already seenstrong interest in functionalisation services from CNT and graphenemanufacturers. We believe that Haydale's process will be a key factor in thesuccess of the entire graphene industry." - ends - For further information please contact: Haydale Graphene Industries plc 01269 842 946John Knowles, ChairmanRay Gibbs, Chief Executive Officer Cairn Financial Advisers LLP (Nomad) 0207 148 7900Tony RawlinsonPaul Trendell Cantor Fitzgerald Europe (Broker) 020 7894 7000David ForemanPaul Jewell Hermes Financial PRTrevor Phillips 07889 153 628Chris Steele 07979 604 687 About Haydale Haydale has developed a patent-pending proprietary scalable plasma process tofunctionalise graphene and other nanomaterials. This enabling technology canprovide Haydale with a rapid and highly cost-efficient method of supplyingtailored solutions to enhance applications for both raw material suppliers andproduct manufacturers. Functionalisation is carried out through a low-pressure plasma process thattreats both mined, organic fine powder and other synthetically producednanomaterial powders, producing high-quality few layered graphenes and graphenenanoplatelets. The process can functionalise with a range of chemical groups,with the level of functionalisation tailored to the customer's needs. Gooddispersion improves the properties and performance of the host material andensures the final product performs as specified. The Haydale plasma process does not use wet chemistry, nor does it damage thematerial being processed; rather, it can clean up any impurities inherent inthe raw material. The technology is a low energy user and most importantlyenvironmentally friendly. The Haydale method is an enabling technology,allowing the Company to work with a raw material producer who seeks to addvalue to the base product and tailor the outputs to meet the targetapplications of the end user. Haydale, based in South Wales and housed in a purpose-built facility forprocessing and handling nanomaterials, is facilitating the application ofgraphenes and other nanomaterials in fields such as inks, sensors, energystorage, photovoltaics, composites, paints and coatings. www.haydale.com About planarTECH LLC Headquartered in The Woodlands, Texas and with regional offices in Korea,planarTECH aims to enable graphene, carbon nanotubes (CNTs), and 2D materialapplications development by providing researchers worldwide with high-qualityscientific & R&D equipment for materials synthesis and characterization. With aglobal network of researchers at leading institutions in Asia, the US andEurope, planarTECH has assembled the process know-how to assist its customersin starting material applications and process development as quickly aspossible. Its customer base includes leading corporate and academic R&D labsaround the world. planarTECH's staff also have extensive experience in the graphene industryspecifically and the electronics supply chain within Asia in general. Drawingon this experience, planarTECH offers customers consulting services to providein-depth knowledge of the graphene and 2D materials market landscape, as wellas market entry advice and access to top-tier OEM partners in Asia (Japan,Korea, Taiwan and China).

http://www.planartech.com

Date   Source Headline
21st May 20267:05 amRNSProposed Commercial Relationship
8th Apr 20265:18 pmRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSNew Contract Signed
26th Mar 20263:39 pmRNSResult of AGM
6th Mar 20261:31 pmRNSInvestor Presentation via Investor Meet Company
2nd Mar 20267:00 amRNSStrategic Digital Infrastructure Partnership
17th Feb 20267:00 amRNSFinal Results and Post-Period Trading Update
11th Feb 20267:00 amRNSNotice of Annual Results
30th Jan 20269:45 amRNSTotal Voting Rights
22nd Jan 20264:54 pmRNSHolding(s) in Company
22nd Jan 20267:00 amRNSHolding(s) in Company
21st Jan 202612:31 pmRNSHolding(s) in Company
15th Jan 20265:01 pmRNSHolding(s) in Company
15th Jan 20262:44 pmRNSChange of Name
12th Jan 20267:00 amRNSCompletion of Acquisition
9th Jan 20266:19 pmRNSDirector/PDMR Dealings
8th Jan 20261:59 pmRNSHolding(s) in Company
8th Jan 20261:55 pmRNSHolding(s) in Company
6th Jan 20262:45 pmRNSResult of General Meeting and Total Voting Rights
22nd Dec 20252:08 pmRNSHolding(s) in Company
22nd Dec 20252:08 pmRNSHolding(s) in Company
16th Dec 202512:45 pmRNSResult of Retail Offer
15th Dec 20259:14 amRNSResult of Accelerated Bookbuild
12th Dec 20257:05 amRNSRetail Offer
12th Dec 20257:00 amRNSProposed Fundraise and Acquisition
2nd Dec 20257:00 amRNSCommercial Update
30th Oct 202510:45 amRNSExpansion of Commercial Platform
23rd Oct 20257:00 amRNSContract Wins
11th Sep 20257:00 amRNSStrategic Collaboration and Trading Update
8th Aug 20257:00 amRNSGrant of Share Options and PDMR Dealings
11th Jul 20258:21 amRNSHolding(s) in Company
30th Jun 20253:14 pmRNSHolding(s) in Company
26th Jun 20252:00 pmRNSSubscriptions, Director Dealings & Issue of Equity
12th Jun 20252:12 pmRNSTrading Update
23rd Apr 20255:22 pmRNSDirectorate Change
17th Apr 202510:46 amRNSCorrection: Haydale US Sales Process Update
17th Apr 20257:00 amRNSHaydale US Sales Process Update
2nd Apr 20257:00 amRNSHaydale Achieves CE Certification
13th Mar 20252:15 pmRNSSubscription, Director Dealings and TVR
13th Mar 20257:00 amRNSInterim Results
7th Mar 202510:18 amRNSHaydale US sales process update
10th Feb 20257:00 amRNSHaydale US placed into insolvency process
30th Dec 20245:20 pmRNSReplacement: Result of AGM
30th Dec 202412:48 pmRNSResult of AGM
23rd Dec 20247:05 amRNSDisposal of Korean Subsidiary
23rd Dec 20247:00 amRNSBusiness Review and Appointment of CEO
6th Dec 20247:00 amRNSPosting of Annual Report and Notice of AGM
4th Dec 20249:44 amRNSHolding(s) in Company
3rd Dec 20245:38 pmRNSHolding(s) in Company
2nd Dec 20247:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.